Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 21, 2017; 23(15): 2743-2749
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743
Esophageal cancer(+) (n = 28) | Esophageal cancer(-) (n = 14762) | PPV, NPV | |
FDG-PET positive (n = 51) | 1 | 50 | PPV 2.0% |
(95%CI: 0.0-10.4) | |||
FDG-PET negative (n = 14739) | 27 | 14712 | NPV 99.8% |
(95%CI: 99.7-99.9) | |||
Sensitivity, specificity | Sensitivity 3.6% | Specificity 99.7% | |
(95%CI: 0.1-18.3) | (95%CI: 99.6-99.7) |
- Citation: Sekiguchi M, Terauchi T, Kakugawa Y, Shimada N, Saito Y, Matsuda T. Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. World J Gastroenterol 2017; 23(15): 2743-2749
- URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2743.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2743